Cargando…

GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE

Introduction: Glioblastoma, IDH-wild type (GBM) is the most common malignant brain tumor with a dismal prognosis. Although its coding region is well-analyzed, little is yet known about the landscape of whole-genome in GBM. Here, we analyzed whole-genome sequencing data from large cohorts to complete...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Takuma, Funakoshi, Yusuke, Uneda, Atsuhito, Nambu, Shohei, Tanaka, Shota, Ishida, Joji, Saito, Ryuta, Hanaya, Ryosuke, Yoshimoto, Koji, Narita, Yoshitaka, Suzuki, Hiromichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719335/
http://dx.doi.org/10.1093/noajnl/vdac167.013
_version_ 1784843300671324160
author Nakashima, Takuma
Funakoshi, Yusuke
Uneda, Atsuhito
Nambu, Shohei
Tanaka, Shota
Ishida, Joji
Saito, Ryuta
Hanaya, Ryosuke
Yoshimoto, Koji
Narita, Yoshitaka
Suzuki, Hiromichi
author_facet Nakashima, Takuma
Funakoshi, Yusuke
Uneda, Atsuhito
Nambu, Shohei
Tanaka, Shota
Ishida, Joji
Saito, Ryuta
Hanaya, Ryosuke
Yoshimoto, Koji
Narita, Yoshitaka
Suzuki, Hiromichi
author_sort Nakashima, Takuma
collection PubMed
description Introduction: Glioblastoma, IDH-wild type (GBM) is the most common malignant brain tumor with a dismal prognosis. Although its coding region is well-analyzed, little is yet known about the landscape of whole-genome in GBM. Here, we analyzed whole-genome sequencing data from large cohorts to completely uncover the genetic aberrations in GBM. Methods: We analyzed 281 whole-genome sequencing data of patients with GBM, of which 152 cases are from our cohort with deep coverage (×120) and 129 cases are from a public database. Results: The median numbers of somatic mutations and structural variants (SVs) per case are 3.0/Mb and 62.5, respectively. While a complex SV is rare in other malignant brain tumors such as IDH-mutant glioma (35% of samples), a large proportion of GBM cases (85%) have complex SV with ≥10 breakpoints. CDKN2A/B homozygous deletions (HDs) are usually comprised of a simple deletion in IDH-mutant glioma whereas about a quarter of CDKN2A/B HDs in GBM are induced by complex SVs. In addition, 30.5% of extrachromosomal DNA (ecDNA) involves multiple chromosomes. Taken together, complex SVs could play a key role in the initiation and progression of GBM. Our deep WGS enables us to delineate a fine view of clonal architecture, where mutational signature varies between clonal and subclonal mutations. The majority of clonal mutations consist of the clock-like signature, whereas subclonal mutations have a relatively low proportion of the clock-like signature. Instead, several other signatures including the APOBEC signature significantly increase in subclones, presuming that various mutational processes along with the clock-like signature contribute to the GBM pathogenesis in its progression phase. Conclusions: GBM evolves through exploiting complex structural variants involving multiple driver genes and the accumulation of genetic mutations caused by distinct mechanisms depending on its developmental stage.
format Online
Article
Text
id pubmed-9719335
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97193352022-12-06 GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE Nakashima, Takuma Funakoshi, Yusuke Uneda, Atsuhito Nambu, Shohei Tanaka, Shota Ishida, Joji Saito, Ryuta Hanaya, Ryosuke Yoshimoto, Koji Narita, Yoshitaka Suzuki, Hiromichi Neurooncol Adv Abstracts Introduction: Glioblastoma, IDH-wild type (GBM) is the most common malignant brain tumor with a dismal prognosis. Although its coding region is well-analyzed, little is yet known about the landscape of whole-genome in GBM. Here, we analyzed whole-genome sequencing data from large cohorts to completely uncover the genetic aberrations in GBM. Methods: We analyzed 281 whole-genome sequencing data of patients with GBM, of which 152 cases are from our cohort with deep coverage (×120) and 129 cases are from a public database. Results: The median numbers of somatic mutations and structural variants (SVs) per case are 3.0/Mb and 62.5, respectively. While a complex SV is rare in other malignant brain tumors such as IDH-mutant glioma (35% of samples), a large proportion of GBM cases (85%) have complex SV with ≥10 breakpoints. CDKN2A/B homozygous deletions (HDs) are usually comprised of a simple deletion in IDH-mutant glioma whereas about a quarter of CDKN2A/B HDs in GBM are induced by complex SVs. In addition, 30.5% of extrachromosomal DNA (ecDNA) involves multiple chromosomes. Taken together, complex SVs could play a key role in the initiation and progression of GBM. Our deep WGS enables us to delineate a fine view of clonal architecture, where mutational signature varies between clonal and subclonal mutations. The majority of clonal mutations consist of the clock-like signature, whereas subclonal mutations have a relatively low proportion of the clock-like signature. Instead, several other signatures including the APOBEC signature significantly increase in subclones, presuming that various mutational processes along with the clock-like signature contribute to the GBM pathogenesis in its progression phase. Conclusions: GBM evolves through exploiting complex structural variants involving multiple driver genes and the accumulation of genetic mutations caused by distinct mechanisms depending on its developmental stage. Oxford University Press 2022-12-03 /pmc/articles/PMC9719335/ http://dx.doi.org/10.1093/noajnl/vdac167.013 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Nakashima, Takuma
Funakoshi, Yusuke
Uneda, Atsuhito
Nambu, Shohei
Tanaka, Shota
Ishida, Joji
Saito, Ryuta
Hanaya, Ryosuke
Yoshimoto, Koji
Narita, Yoshitaka
Suzuki, Hiromichi
GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE
title GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE
title_full GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE
title_fullStr GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE
title_full_unstemmed GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE
title_short GEN-10 WHOLE GENOME LANDSCAPE OF GLIOBLASTOMA, IDH-WILD TYPE
title_sort gen-10 whole genome landscape of glioblastoma, idh-wild type
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719335/
http://dx.doi.org/10.1093/noajnl/vdac167.013
work_keys_str_mv AT nakashimatakuma gen10wholegenomelandscapeofglioblastomaidhwildtype
AT funakoshiyusuke gen10wholegenomelandscapeofglioblastomaidhwildtype
AT unedaatsuhito gen10wholegenomelandscapeofglioblastomaidhwildtype
AT nambushohei gen10wholegenomelandscapeofglioblastomaidhwildtype
AT tanakashota gen10wholegenomelandscapeofglioblastomaidhwildtype
AT ishidajoji gen10wholegenomelandscapeofglioblastomaidhwildtype
AT saitoryuta gen10wholegenomelandscapeofglioblastomaidhwildtype
AT hanayaryosuke gen10wholegenomelandscapeofglioblastomaidhwildtype
AT yoshimotokoji gen10wholegenomelandscapeofglioblastomaidhwildtype
AT naritayoshitaka gen10wholegenomelandscapeofglioblastomaidhwildtype
AT suzukihiromichi gen10wholegenomelandscapeofglioblastomaidhwildtype